Gem Pharmaceuticals LLC
Other · AL · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Monopar TherapeuticsActivist (13D)Feb 7, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Recent SEC filings
All filings ↗- SCHEDULE 13D/AFeb 7, 2025
- SC 13DPRIMARY DOCUMENTDec 23, 2019
- 3PRIMARY DOCUMENTJan 8, 2018
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.